Patients with osteoarthritis of the knee: management in the outpatient setting
https://doi.org/10.21518/2079-701X-2021-2-86-93
Abstract
The article discusses the treatment of osteoarthritis. To prevent serious structural and functional changes, it is extremely important to start therapy in the early stages of the disease. Symptomatic slow-acting drugs for the treatment of osteoarthritis (SYSADOA) are an important class in the pharmacological arsenal of OA treatment. The results of the use of this group of drugs in numerous clinical studies have demonstrated good effectiveness in the long-term achievement of the goal. The SYSADOA class (chondroprotectors) includes many different drugs, including glucosamine, chondroitin, diacerein, and soy unsaponifiable avocado substances. Particular attention is paid to the injectable forms of chondroprotective drugs, data from experimental and clinical studies confirming their effectiveness. The authors discuss the issue of intra-articular administration of drugs for knee osteoarthritis and the choice of optimal access. Intra-articular drug delivery has a number of advantages over systemic delivery, including increased local bioavailability, reduced systemic exposure, fewer side effects, and reduced cost. To minimize side effects, it is important to determine the injection site and to have some preparation in the correct placement of the needle during these procedures. To improve the accuracy of intraarticular injections, various imaging methods can be used, but ultrasound of the musculoskeletal system is the most practical. The article presents the data of personal experience of choosing access under the control of ultrasound. Taking into account the anatomy of the knee joint, performing an intra-articular injection from the inside into the upper inversion is the most affordable and optimal. The article presents the data of a clinical example of the introduction of chondroprotectors through the selected access.
About the Authors
Yu. S. Filatova
Yaroslavl State Medical University; Center for diagnostics and prevention
Russian Federation
Russian Federation
Yulia S. Filatova, Cand. of Sci. (Med.), Associate Professor of the Department of therapy named after E.N. Dormidontov, Institute of Postgraduate Education, Yaroslavl State Medical University; Rheumatologist, Center for diagnostics and prevention
5, Revolyutsionnaya St., Yaroslavl, 150000
33, Lenin Ave., Yaroslavl, 150003
I. N. Solovyov
Yaroslavl State Medical University; Center for diagnostics and prevention
Russian Federation
Russian Federation
Igor N. Solovyov, Cand. of Sci. (Med.), Associate Professor of the Department of traumatology and orthopedics, Yaroslavl State Medical University; Traumatologist- O rthopedist, Center for diagnostics and prevention
5, Revolyutsionnaya St., Yaroslavl, 150000
33, Lenin Ave., Yaroslavl, 150003
References
1. Grässel S., Muschter D. Recent advances in the treatment of osteoarthritis. F1000Res. 2020;9:F1000. doi: 10.12688/f1000research.22115.1.
2. Felson D.T. Epidemiology of hip and knee osteoarthritis. Epidemiol Rev. 1988;10:1–28. doi: 10.1093/oxfordjournals.epirev.a036019.
3. Balabanova R.M., Erdes S.F. Trends in the prevalence of rheumatic diseases in ICD-10 in the adult population of the Russian Federation over 20002010. Nauchno-prakticheskaya revmatologiya = Rheumatology Science and Practice. 2012;50(3):10–12. (In Russ.) doi: 10.14412/1995-4484-2012-702.
4. Goldring S.R., Goldring M.B. Changes in the osteochondral unit during osteoarthritis: structure, function and cartilage-bone crosstalk. Nat Rev Rheumatol. 2016;12(11):632–644. doi: 10.1038/nrrheum.2016.148.
5. Bruyere O., Cooper C., Pelletier J.P., Branco J., Brandi M.L., Guillemin F. et al. An algorithm recommendation for the management of knee osteoarthritis in Europe and internationally: a report from a task force of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Semin Arthritis Rheum. 2014;44(3):253–263. doi: 10.1016/j.semarthrit.2014.05.014.
6. Bartels E.M., Bliddal H., Schondorff P.K., Altman R.D., Zhang W., Christensen R. Symptomatic efficacy and safety of diacerein in the treatment of osteoarthritis: a meta-analysis of randomized placebo-controlled trials. Osteoarthritis Cartilage. 2010;18(3):289–296. doi: 10.1016/j.joca.2009.10.006.
7. Towheed T.E., Maxwell L., Anastassiades T.P., Shea B., Houpt J., Robinson V. et al. Glucosamine therapy for treating osteoarthritis. Cochrane Database Syst Rev. 2005;(2):CD002946. doi: 10.1002/14651858.CD002946.pub2.
8. Singh J.A., Noorbaloochi S., MacDonald R., Maxwell L.J. Chondroitin for osteoarthritis. Cochrane Database Syst Rev. 2015;1:CD005614. doi: 10.1002/14651858.CD005614.pub2.
9. Olariu L., Pyatigorskaya N., Dumitriu B., Pavlov A. “In vitro” chondro-restitutive capacity of Alflutop® proved on chondrocytes cultures. Romanian Biotechnol Letters. 2016;22(6):12047–12053. Available at: https://www.researchgate.net/publication/316887165_In_vitro_chondro-restitutive_capacity_of_AlflutopR_proved_on_chondrocytes_cultures.
10. Olariu L., Dumitriu B., Buse E., Rosoiu N. The in vitro effect of Alflutop® product on some extracellular signaling factors involved in the osteoarthicular pathology inflammation. Academy of Romanian Scientists Annals – Series on Biological Sciences. 2015;4(2):7–17. Available at: http://aos.ro/wp-content/anale/BVol4Nr2Art.1.pdf.
11. Groppa L., Mynzatu I., Karasava M. Alflutop efficacy in patients with deforming osteoarthritis. Klinicheskaya revmatologiya = Clinical Rheumatology. 1995;(3):20–22. (In Russ.)
12. Buckland-Wrighr J.C., Wolfe F., Ward R.J., Flowers N., Hayne C. Substantial superiority of semiflrxed (MTP) views in knee osteoarthritis: a comparative radiographic study? Without fluoroscopy of sanding extended, semiflexed (MTP), and schuss views. J Rheumatol. 1999;26(12):2664–2674. Available at: https://pubmed.ncbi.nlm.nih.gov/10606380/.
13. Korshunov N.I., Marasaev V.V., Baranova E.Ya., Parusova N.I., Lutskova L.N. Role of an inflammation and assessment of hondroprotektivny action of Alflutop at patients with osteoarthrosis according to a magnetic and resonant tomography of a knee joint. RMZh = RMJ. 2003;(23):1320. (In Russ.) Available at: https://www.rmj.ru/articles/revmatologiya/Roly_vospaleniya_i_ocenka_hondroprotektivnogo_deystviya_Alflutopa_u_bolynyh_osteoartrozom_po_dannym_magnitno-rezonansnoy_tomografii_kolennogo_sustava/.
14. Alekseeva L.I., Sharapova E.P., Taskina E.A., Chichasova N.V., Imametdinova G.R., Shostak N.A. et al. Multicenter double-blind randomized placebocontrolled trial of the symptom- and structure-modifying effect of alflutop in patients with knee osteoarthrosis. Communication 1. Evaluation of the symptom-modifying effect of the drug. Nauchno-prakticheskaya revmatologiya = Rheumatology Science and Practice. 2013;51(5):532–538. (In Russ.) doi: 10.14412/1995-4484-2013-1545.
15. Alekseeva L.I., Sharapova E.P., Taskina E.A., Chichasova N.V., Imametdinova G.R., Shostak N.A. et al. A multicenter, blind, randomized, placebo-controlled study of the symptom- and structure-modifying effect of Alflutop in patients with knee osteoarthrosis. Report 2: the assessment of the structure-modifying effect of the drug. Nauchno-prakticheskaya revmatologiya = Rheumatology Science and Practice. 2014;52(2):174–177. (In Russ.) doi: 10.14412/1995-4484-2014-174-177.
16. Lukina G.V., Sigidin J.A., Chichasova N.V., Imametdinova G.R., Lobzanidse T.B., Pushkova O.V., Severinova M.V. et. аl. Alflutop in osteoarthritis therapy. Nauchno-prakticheskaya revmatologiya = Rheumatology Science and Practice. 2004;42(3):52–54. (In Russ.) doi: 10.14412/1995-4484-2004-1481.
17. Svetlova M.S., Kheifets I.V. Еffect of long-term afflutop therapy on the arthrosonographic changes in patients with knee osteoarthritis. Meditsinskiy sovet = Medical Council. 2018;(1):104–110. (In Russ.) doi: 10.21518/2079-701X-2018-1-104-110.
18. Voyshcheva E.A., Voyshchev L.S., Semagina O.V., Saktser Yu.M., Klimova L.A., Adusheva N.V. Intraarticular and intramuscular use of alflutop n patients with gonarthrosis. Vestnik meditsinskogo instituta «REAVIZ» = Bulletin of the Medical Institute «REAVIZ». 2019;(2):109–112. (In Russ.) Available at: http://vmi-reaviz.ru/wp-content/uploads/2019/06/Vestnik-2-38-2019.pdf.
19. Noskov S.M., Sherina T.A., Parulya O.M. The role of Alflutop in the treatment of primary osteoarthritis. Terapiya = Therapy. 2016;(2):65–69. (In Russ.) Available at: https://elibrary.ru/item.asp?id=26040661.
20. Emami A., Tepper J., Short B., Yaksh T.L., Bendele A.M., Ramani T. et al. Toxicology Evaluation of Drugs Administered via Uncommon Routes: Intranasal, Intraocular, Intrathecal/Intraspinal, and Intra-Articular. Int J Toxicol. 2018;37(1):4–27. doi: 10.1177/1091581817741840.
21. Evans C.H., Kraus V.B., Setton L.A. Progress in intra-articular therapy. Nat Rev Rheumatol. 2014;10(1):11–22. doi: 10.1038/nrrheum.2013.159.
22. Bannuru R.R., Natov N.S., Dasi U.R., Schmid C.H., McAlindon T.E. Therapeutic trajectory following intra-articular hyaluronic acid injection in knee osteoarthritis meta-analysis. Osteoarthritis Cartilage. 2011;19(6):611–619. doi: 10.1016/j.joca.2010.09.014.
23. Jackson D.W., Evans N.A., Thomas B.M. Accuracy of needle placement into the intra-articular space of the knee. J Bone Joint Surg Am. 2002;84(9):1522–1527. doi: 10.2106/00004623-200209000-00003.
24. Sethi P.M., Kingston S., Elattrache N. Accuracy of anterior intra-articular injection of the glenohumeral joint. Arthroscopy. 2005;21(1):77–80. doi: 10.1016/j.arthro.2004.09.009.
25. McGarry J.G., Daruwalla Z.J. The efficacy, accuracy and complications of corticosteroid injections of the knee joint. Knee Surg Sports Traumatol Arthrosc. 2011;19(10):1649–1654. doi: 10.1007/s00167010-1380-1.
26. Bellamy N., Campbell J., Robinson V., Gee T., Bourne R., Wells G. Intraarticular corticosteroid for treatment of osteoarthritis of the knee. Cochrane Database Syst Rev. 2006;(2):CD005328. doi: 10.1002/14651858.CD005328.
27. Iagnocco A., Naredo E. Ultrasound-guided corticosteroid injection in rheumatology: accuracy or efficacy? Rheumatology (Oxford). 2010;49(8):14271428. doi: 10.1093/rheumatology/keq081.
28. Louis L.J. Musculoskeletal ultrasound intervention: principles and advances. Radiol Clin North Am. 2008;46(3):515–533. doi: 10.1016/j.rcl.2008.02.003.
29. Epis O., Iagnocco A., Meenagh G., Riente L., Delle Sedie A., Filippucci E. et al. Ultrasound imaging for the rheumatologist. XVI. Ultrasound-guided procedures. Clin Exp Rheumatol. 2008;26(4):515–518. Available at: https://www.clinexprheumatol.org/abstract.asp?a=3399.
30. Berkoff D.J., Miller L.E., Block J.E. Clinical utility of ultrasound guidance for intra-articular knee injections: a review. Clin Interv Aging. 2012;7:89–95. doi: 10.2147/CIA.S29265.
31. Belova K.Yu., Nazarova A.V. Strategy for the management of osteoarthritis in multimorbid patients: the balance of effectiveness and safety while choosing drug therapy. Meditsinskiy sovet = Medical Council. 2020;(11):164–176. (In Russ.) doi: 10.21518/2079-701X-2020-11-164-176.
32. Filatova Yu.S., Solovyov I.N. Management tactics for patients with osteoarthritis: a joint view of a rheumatologist and an orthopedic traumatologist. Meditsinskiy sovet = Medical Council. 2020;(19):89–97. (In Russ.) doi: 10.21518/2079-701X-2020-19-89-97.
Review
For citations:
Filatova YS, Solovyov IN. Patients with osteoarthritis of the knee: management in the outpatient setting. Meditsinskiy sovet = Medical Council. 2021;(2):86-93. (In Russ.) https://doi.org/10.21518/2079-701X-2021-2-86-93
Views:
714
Email this article 